Welcome to the 7th International Cancer Cluster Showcase!
Cutting edge oncology innovations from leading North American and European industry clusters will be presented in compact 4 min presentations giving you the opportunity to learn about the latest innovations from about 20+ companies.
11:30 – 12:30 p.m. REGISTRATION AND LIGHT LUNCH with POSTER SESSION
12:30 – 12:45 p.m. Opening and Welcome by ICCS: Organizing Partners and Sponsors Welcome Notes by Allison Hilton, Senior Advisor, Healthcare Corporate Banking, DNB Healthcare and by Pat Devitt – President of Precision Oncology
12:45 – 1:15 p.m. Company pitches I: Immunovaccine (IMV) Inv. Alligator Bioscience Avvinity Therapeutics Third Coast Therapeutics OncoImmunity Leuko Labs Inc. 1:15 – 1:25 p.m. Boehringer Ingelheim Presentation, Scott DeWire, Global Head of BD&L Cancer Immunology, Immune Modulation and Biotherapeutics
1:25 – 1:50 p.m. Company Pitches II: Amal Therapeutics TYG Oncology Ultimovacs Context Therapeutics IPD Discovery Pharma MIMS
1:50 – 2:15 p.m. NETWORKING BREAK & POSTER SESSION
2:15 – 2:20 p.m. Takeda Oncology Presentation, Paul E. Juniewicz, Senior Director, Oncology Search & Evaluation, Center for External Innovation
2:20 – 2:50 p.m. Company Pitches III: Bessor Pharma Eritech MBF Therapeutics Immune Biosolutions Simplicity Bio FIMMIC
2:50 – 3:00 p.m. Angel Group – Oncology Focus (details tbc)
3:00 – 3:30 p.m. Company Pitches IV: ABIVAX F-Star ASCIL Biopharm Phi Pharma CytoSavvy Final company to be announced
3:30 – 3:35 p.m. Closing Remarks
3:35 – 4:30 p.m. NETWORKING RECEPTION & POSTER SESSION
Partners from Oslo, Massachusetts, Philadelphia, Quebec, UK Golden Triangle, Catalonia, and the Paris Region are teaming up again to present their oncology pipelines as a satellite event to BIO 2018.
Oslo Cancer Cluster is one of the program supporters.